Microplasmin: Ex Vivo Characterization of Its Activity in Porcine Vitreous METHODS
|
|
- Leon Cox
- 5 years ago
- Views:
Transcription
1 Microplasmin: Ex Vivo Characterization of Its Activity in Porcine Vitreous Marc D. de Smet, 1,2 Christophe Valmaggia, 1,3 Javier Zarranz-Ventura, 4 and Ben Willekens 5 PURPOSE. Microplasmin is a recombinant protein limited to the enzymatic moiety of plasmin without any of its cringle domains. Its enzymatic activity is similar to that of plasmin enzyme. The present study characterizes in a porcine eye model the vitreolytic ability of microplasmin. METHOD. Freshly harvested porcine eyes were used in these trials. Eyes were injected with escalating doses of microplasmin (62.5, 125, 250, 400 g) for 1 hour or with 125 g microplasmin with increasing time exposures (15, 30, 60, 120 minutes). Eyes were fixed by a very slow dehydration process to preserve the integrity of the vitreous retinal interface. They were examined by light microscopy to determine the degree of posterior vitreous detachment and by scanning electron microscopy (SEM) to study structural changes. RESULTS. Effective separation of the posterior hyaloid appeared to be dose dependent. After 1 hour, the posterior pole was detached in 100% of porcine eyes exposed to 125 g microplasmin and in the midperiphery to 250 g microplasmin. Vitreous at the ora did not detach. At 120 minutes of exposure, midperipheral detachment was observed with 125 g microplasmin. A smooth retinal surface was seen where the enzyme caused posterior vitreous detachment. There was also significant change to the integrity of the vitreous without any obvious structural alterations to the retina by histology or scanning electron microscopy. CONCLUSIONS. Microplasmin caused vitreolysis and posterior vitreous separation in an ex vivo porcine eye model in an apparent dose- and time-dependent fashion. In this model system, the minimal effective dose appeared to be 125 g. (Invest Ophthalmol Vis Sci. 2009;50: ) DOI: /iovs Inducing posterior vitreous detachment by pharmacologic means has been a longstanding goal of vitreoretinal surgeons. 1 3 A few decades ago, reports appeared suggesting that spontaneous posterior vitreous detachment (PVD) would decrease the risk for or lead to the resolution of proliferative disease. 4 6 Surgically producing an atraumatic separation of From the 1 Department of Ophthalmology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2 Division of Vitreo-retinal Surgery and Uveitis, Department of Ophthalmology, Middelheim Hospital, Antwerp, Belgium; 3 Department of Ophthalmology, Kantonsspital St. Gallen, St. Gallen, Switzerland; 4 Faculty of Medicine, University of Navarra, Pamplona, Spain; and 5 Department of Morphology, Netherlands Institute for Neurosciences, Amsterdam, The Netherlands. Submitted for publication April 19, 2008; revised June 21 and September 3, 2008; accepted November 3, Disclosure: M.D. de Smet, ThromboGenics Ltd. (F, C), P; C. Valmaggia, ThromboGenics Ltd. (F); J. Zarranz-Ventura, Thrombo- Genics Ltd. (F); B. Willekens, ThromboGenics Ltd. (F) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked advertisement in accordance with 18 U.S.C solely to indicate this fact. Corresponding author: Marc D. de Smet, Department of Ophthalmology, Middelheim Hospital, Lindendreef 1, Antwerp 2000, Belgium; mddesmet1@mac.com. the posterior vitreous face achieves the same goals but may be difficult to induce. Incomplete separation can lead to disease progression, whereas firm adhesions between the hyaloidal face and the underlying retina can lead to damage of the underlying structures. 7 Several compounds, both enzymatic and nonenzymatic, have been tried as vitreolytic agents One of the most promising and extensively tested in humans has been the serine protease plasmin. Its efficacy in producing PVD has been documented in a number of studies However, producing autologous plasmin is a labor- and time-intensive process that most clinical laboratories are unable or unwilling to carry out. The final product is difficult to characterize and is inherently unstable. A more suitable alternative should ideally retain the biological activity but be pharmacologically fully characterized. Microplasmin is a recombinant protein, a truncated form of human plasmin that lacks all five kringle domains but retains the protease activity. 20 Produced in Pichia pastoris, the recombinant protein is stabilized in a dilute citrate buffer at ph 3.1 and is lyophilized. Its half-life in blood is several times higher than in plasmin, whereas its biological activity in models of peripheral arterial occlusion and ischemic stroke are similar to that in intact plasmin enzyme. Early studies in cat and rabbit models have shown its safety in animal eyes. 14,21 The present study was designed to characterize the enzymatic activity of recombinant microplasmin on the vitreous interface in an ex vivo porcine model system in which artifactual separation of the vitreous from the retinal surface was minimized. In this system, dose and time exposure were evaluated by light microscopy (LM) and electron microscopy (EM). METHODS Enzyme Preparation and Injection Procedure Microplasmin was provided by ThromboGenics Ltd. (Dublin, Ireland). The solution was stored at 20 C until needed. Just before use, the solution was thawed, diluted to the appropriate concentration under sterile conditions with balanced salt solution plus (BSS ; Alcon Laboratories, Fort Worth, TX), and kept on ice until use. The injections were given with a maximal delay of 15 minutes, after which a new vial of microplasmin was prepared. In all experiments, fresh cadaver pig eyes were obtained from a local slaughterhouse. To ensure freshness, the eyes were obtained directly after the animal was killed and were cleaned and gutted. The procedure never took longer than 10 minutes. One hundred microliters of the appropriate concentration of microplasmin or physiologic saline was injected into the eye through the pars plana 3 mm posterior to the limbus. The site of injection was marked on the surface of the sclera with indelible ink. Eyes were kept at ambient temperature (20 C 25 C) for the duration of the incubation period and were then processed as described. Fixation Procedure and Preparation for Light and Electron Microscopy Preliminary studies were conducted to determine the best fixation, embedding, and staining methodology to minimize interference with Investigative Ophthalmology & Visual Science, February 2009, Vol. 50, No Copyright Association for Research in Vision and Ophthalmology
2 IOVS, February 2009, Vol. 50, No. 2 Microplasmin 815 the vitreoretinal interface on LM and on EM. The resultant protocol is summarized in this article. Additional studies were carried out to ensure that the vitreoretinal interface would not undergo any alteration caused by autolysis at the maximal incubation period used in these studies. With fresh porcine globes, it was determined that autolysis becomes significant at 24 hours of incubation at room temperature. Slow progressive dehydration and the use of whole globes was felt to be critical to avoid artifactual separation of the vitreous from the retina. To stop enzymatic reaction and to facilitate intraocular fixation, a 4- to 6-mm scleral opening was made parallel to the pars plana at least 90 away from the site of injection, and between 0.2 ml and 0.4 ml fixative was injected directly into the eye, toward the midvitreous. The eyes were left in a mixture of 1.25% glutaraldehyde and 1% paraformaldehyde in 0.08 M cacodylate buffer (ph 7.4) at room temperature for 3 days. Then they were slowly dehydrated in progressively higher concentrations (up to 100%) of ethanol over a 4-week period. After complete dehydration, the eyes were cut in two equal parts with a sharp scalpel blade. The incision was placed in the anteroposterior axis of the injection site. Photographs were taken of the eyecups. Half of each eye was used for LM, and the other half was used for scanning EM (SEM). The specimen for LM was placed in embedding resin (Technovit 7100; Heraeus Kulzer GmbH, Wehrheim/ts, Germany) in accordance with the manufacturer s instructions. Serial 4- m thick slices were obtained, placed on a glass slide, and stained with 1% toluidine blue. The specimen for EM was immersion dried in hexamethyldisilazane (Sigma-Aldrich, St. Louis, MO), mounted with carbon glue on special stubs, and coated with 8 nm platinum. Slides were examined and photographed under an SEM (XL20; Philips, Eindhoven, Netherlands). Effect of Concentration on Vitreous Separation Experiments were directed at determining the effect of different concentrations of microplasmin on the vitreous interface. For each concentration, four eyes were used and incubated for 60 and 120 minutes at room temperature. Eyes were injected as described. Concentrations tested were 62.5, 125, 250, and 400 g. Eyes were examined for gross changes in the appearance of the vitreous and retina and for the presence of a PVD. At each concentration, two eyes were examined by EM in representative areas of the retina. Effect of Time Exposure to a Fixed Dose of Microplasmin The effect of time exposure to a fixed dose of microplasmin was assessed, with the minimal effective dose of 125 g injected in the midvitreous of fresh porcine eyes. For each time point, four eyes were used. Eyes were injected as described and were incubated at room temperature for 15, 30, 60, or 120 minutes. After processing, the eyes were submitted to LM and were evaluated for the presence of complete separation of the posterior hyaloid (in which case a clear posterior hyaloid was seen in the vitreous distant from the retinal surface or the absence of any cellular or fibrillar structure on the retinal surface), partial separation, or complete adherence of the vitreous to the retina. FIGURE 1. Light micrograph showing the retina-vitreous interface. The dose of microplasmin used is shown in the lower right corner of each image. Eyes were treated for 1 hour. Top: no separation of the vitreous face. Middle: partial separation (arrows) adjacent to the retina. Lower: complete separation along the full length of the retina. This was assessed for the posterior pole, midvitreous, and the area proximal to the ora serrata. Assessment of Retinal and Zonular Integrity The integrity of retinal structures was assessed by reviewing the LM slides of eyes injected with ascending concentrations or ascending time exposure for signs of vacuolation within the retina. Transmission electron micrographs were obtained from eyes exposed to 125 g microplasmin for 120 minutes. Zonular integrity was assessed by SEM in the same specimen. RESULTS After the best fixation and staining technique were determining, the effect of varying doses of microplasmin was determined in pig eyes (Table 1). The lowest dose did not cause any hyaloid separation at either 1 or 2 hours of exposure. At 125 g microplasmin, complete separation of the posterior hyaloid along the retinal surface occurred in half the eyes exposed for 1 hour (Figs. 1, 2). Consistent posterior hyaloid separation was achieved at doses of 125 g and higher, injected into midvitreous for 2 hours. As shown in Figure 1, separation was consistently greater in eyes receiving 250 g microplasmin than in eyes receiving 125 g microplasmin, possibly indicating a more TABLE 1. Vitreous Separation Assessed by Light Microscopy after Exposing Eyes at Room Temperature to Various Concentrations of Microplasmin in BSS for 1 Hour Concentration ( g) Near Optic Nerve Mid Periphery Ora Serrata Control N5 N5 N N4 N4 N4 125 C4 C1P3 N4 250 C4 C4 N4 400 C4 C4 N4 C, complete separation; P, partial separation; N, no separation. FIGURE 2. Light micrograph taken of the vitreoretinal interface after 60 minutes of exposure to 125 g microplasmin. Left: complete separation of the posterior hyaloid adjacent to the retina. Right: atthe level of the ora, the vitreous face is still intact, except for one small area overlying the pars plana.
3 816 de Smet et al. IOVS, February 2009, Vol. 50, No. 2 TABLE 2. Vitreous Separation Assessed by Light Microscopy over Time at Room Temperature for Different Locations after Injection of 125 g Microplasmin in Porcine Eyes Time after Injection (min) Near Optic Nerve Mid Periphery Ora Serrata Control (120) N8 N8 N8 MP (15) P3 N1 N4 N4 MP (30) C2 N2 P2 N2 N4 MP (60) C4 C3 P1 N4 MP (120) C4 C4 P1* N3 MP, microplasmin. * Partial separation of the vitreous over the pars plana. effective posterior hyaloid separation. The time course of the vitreous separation was studied with a dose of 125 g (Table 2). Progressively more prominent separation was achieved over time with 1 hour of exposure required for a consistent separation at the posterior pole. No separation was seen over the ora serrata (Fig. 2). The retinal-vitreous interface was studied by EM in eyes injected with 125 g microplasmin for 2 hours and were compared with control eyes (Figs. 3, 4). The retinal surface of the treated eye had a smooth appearance, characterized by total or near total absence of vitreous strands. As with LM, occasional cells were seen on the retinal surface (Figs. 4F, 5). Although their appearance was sporadic at a concentration of 125 g, they were more frequently seen at the highest concentration, though their number per high-power field was limited to three cells or less. Al- FIGURE 3. Composite image taken of a globe injected with physiologic saline. (A) Vitreous remains translucent despite dehydration. (B) Eponembedded fragments and identification of the site studied in (C) located close to the ora serrata. (C) Eponembedded fragment at higher power showing the site studied in (D) and (E) (white rectangle) and in (F) and (G)(black rectangle). (D) Vitreous at higher magnification ( 1500) showing a fibrillar structure in an area overlying a vessel. (E) Higher magnification ( 12000) of the vitreous in (D) showing a meshwork of vitreous fibers. (F) Vitreous overlying the retina proper at 1500 showing a meshwork of vitreous fibers. (G) Higher magnification from (F). (H) Epon-embedded fragment from the posterior pole and identification of the site studied in (I). (I) The vitreous overlying the vessel also has a fibrillar structure. (J) Higher magnification of (I).
4 IOVS, February 2009, Vol. 50, No. 2 Microplasmin 817 FIGURE 4. Composite image of a globe injected with 125 g microplasmin and 2-hour incubation. (A) Vitreous is hazy after fixation. (B) Epon-embedded fragment of the peripheral retina. A vitreous strand is visible with surrounding bare retina. Locations of sites studied at higher power in (D) and (E) are indicated. (C) Epon-embedded posterior pole of the same eye showing location magnified in (F). (D) Smooth retinal surface with minimal vitreous strand close to vitreous base. (E) Vitreous fragment showing the lack of fibrillar structure. (F) Smooth retinal structure devoid of vitreous elements. (G) Fragment showing location of higher magnification images (H) and (I). (H) Ciliary processes and zonules appear intact. (I) Vitreous in this location over the peripheral retina retains a normal fibrillar appearance. though their nature was not determined, they had a dendritic appearance and were invariably located on the retinal surface. Vitreous adjacent to areas with a smooth retinal surface had a ground-glass appearance (Fig. 4). Along the vitreous base, the vitreous retained a more fibrillar consistency. Gross examination FIGURE 5. Cell with numerous dendritic extensions on the surface of the retina. These cells were observed primarily with higher concentrations of microplasmin and at higher exposures. (A) SEM image. (B) Transmission EM. FIGURE 6. Image taken of a globe opened after fixation and showing circumscribed elevations of retina and RPE after 120-minute exposure to 400 g microplasmin.
5 818 de Smet et al. IOVS, February 2009, Vol. 50, No. 2 showed that the vitreous of injected eyes in which vitreous degradation had occurred, based on LM or EM, had a hazy appearance after fixation (compares Figs. 4 and. 3). By gross examination and on LM, pigment epithelial separation was seen in 25% of the eyes injected with the highest concentration (400 g) at 120 minutes (Fig. 6). A similar result was observed in a repeat experiment using the same concentration and exposure. The overlying retina appeared normal in appearance, as did the RPE. Examination of the ciliary body and zonules adjacent to the site of injection on SEM did not reveal any significant abnormality (Fig. 4H). DISCUSSION The present study demonstrates the efficacy of microplasmin in separating the posterior hyaloid from the inner limiting membrane. In this porcine eye model, complete separation at the vitreoretinal interface was achieved in a time- and dosedependent fashion without morphologic changes. The separation appeared to first develop in the posterior pole region and to extend to the periphery. As with other vitreolytic enzymes, no separation was observed in the region of the pars plana. 16,22 The observed activity profile is similar to that of plasmin enzyme. The effective microplasmin dose of 125 g is comparable to that of plasmin (2 U), which causes complete vitreoretinal separation in porcine and human eyes. 12,19 In our current series, a consistent effect was noticed at 1 hour rather than 30 minutes, as reported by other investigators 14,21 for the cat and human vitreous. This difference may lie in the tighter vitreoretinal junction in the relatively young animals used and in the effect of a lower incubation temperature. Slow dehydration and processing would also minimize artifactual separation between the retina and the posterior vitreous face, which could occur as a result of incubation with a vitreolytic enzyme. Indeed early attempts in nontreated eyes with a faster dehydration process or the use of a punch biopsy did lead to artifactual vitreoretinal separation. Staining and processing of the tissue for light microscopy was also complicated because the interface is often damaged during the cutting process. This was minimized using the embedding resin (Technovit 7100; Heraeus Kulzer GmbH) fixative. Our experiments suggest that after injection of the enzyme in midvitreous, the process starts close to the optic nerve and moves to the periphery. Higher doses lead to a more complete effect with a greater separation between the posterior hyaloid face and the retinal surface (Fig. 1). Such a separation may indicate that the vitreoretinal interface is detached over a larger retinal surface area, allowing more retraction of the vitreous body. Indeed, the vitreolytic effect did not appear to be homogeneous throughout the eye after fixation. The area proximal to the site of injection frequently appeared to be more detached than areas distal to the site of injection. It is likely that the clinical effect will also be polarized because it is more prominent in the area proximal to the injection site. Accurate placement of the enzyme close to the area where its effect is anticipated may be important. Electron micrographs show that incubation with 125 g microplasmin does not affect the structural integrity of the retina. It provides a smooth retinal surface devoid of vitreous strands. Adjacent to these areas, vitreous takes on a granular appearance and loses its fibrillar structure. However, more distal to the injection site (e.g., adjacent to the ora, as in Fig. 4I), the vitreous fibrillar structure is maintained. Although this may in part reflect a difference in chemical structure in vitreous adjacent to the vitreous base, 23 it may reflect a lack of exposure to the enzyme that must diffuse to this particular location from its site of injection. Protein diffusion through a macromolecular matrix is slower than through a liquid 24 and may take many hours to occur. In the course of these experiments, we examined ascending doses of microplasmin to determine which doses would be safe for further in vivo evaluation. Doses up to 250 g appeared to differ only in their ability to induce progressively more pronounced PVD. The highest dose tested, 400 g, was associated with the appearance of dendritic-like cells on the retinal surface (Fig. 5) and the appearance of circumscribed elevations of the retina and RPE in serous-like detachments measuring approximately 2 to 3 disc diameters (Fig. 6). These were present in approximately 25% of the eyes examined, always in association with the dendritic-like cells. They were more frequent with more prolonged incubations (120 minutes). When present, multiple lesions were observed in the same eye. These observations suggest an upper limit on the potential therapeutic use of microplasmin in ocular tissues. In other experiments, porcine eyes were exposed to 125 g microplasmin for up to 24 hours. We did not observe the development of these RPE detachments over this prolonged exposure time. Caution should be taken in extending our results to an in vivo setting. Our experiments were carried out in an ex vivo model. Although we took care to avoid incubations that would lead to visible autolysis (intracellular vacuolation in retinal tissue), autolysis is likely to begin shortly after death. It is likely to affect layers adjacent to the pigment epithelium, where autolysis is most active. In summary, microplasmin is an effective agent to separate the posterior hyaloid. The effect appeared, in this limited study, to be dose and time dependent and to extend in a centrifugal fashion from its initiation point. An effective dose appeared to be approximately 125 g, with a possible upper limit placed at 400 g in this porcine eye model. Two hours seemed to be the time needed for complete separation out to the ora with the 125- g dose. References 1. Bhisitkul RB. Anticipation for enzymatic vitreolysis. Br J Ophthalmol. 2001;85: Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol. 2000; 15: Sebag J. Is pharmacologic vitreolysis brewing? Retina. 2002;22: Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol. 1965;74: Foos RY, Kreiger AE, Forsythe AB, Zakka KA. Posterior vitreous detachment in diabetic subjects. Ophthalmology. 1980;87: Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology. 1990;97: Johnson MW. Perifoveal vitreous detachment and its macular complications. Tr Am Ophthalmol Soc. 2005;103: O Neill R, Shea M. The effects of bacterial collagenase in rabbit vitreous. Can J Ophthalmol. 1973;8: Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, The Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005;140: Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina. 1998;18: Oliveira LB, Meyer CH, Kumar J, et al. RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacological vitreolysis. Curr Eye Res. 2002;25: Gandorfer A, Putz E, Wege-Lüssen U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6 10.
6 IOVS, February 2009, Vol. 50, No. 2 Microplasmin Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye. 2002;16: Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004; 45: Gandorfer A, Kampik A. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol. 2005;139: Gandorfer A, Priglinger S, Schebitz K, et al. Vitreous morphology of plasmin treated human eyes. Am J Ophthalmol. 2002;133: Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107: Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19: Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105: Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: production and potential therapeutic properties. J Thrombosis Haemost. 2003;1: Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci. 2005;46: Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111: Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Ret Eye Res. 2000;19: Pluen A, Netti PA, Jain RK, Berk DA. Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J. 1999;77:
Long-term Effect of Plasmin on the Vitreolysis in Rabbit Eyes
Korean J Ophthalmol Vol. 18:35-40, 2004 Long-term Effect of Plasmin on the Vitreolysis in Rabbit Eyes Nam Ju Kim, MD*, Hyeong Gon Yu, MD*, * *, Young Suk Yu, MD*, * *, Hum Chung, MD*, * * *Department of
More informationEarly diagnosis and treatment of VMT with single Intravitreal Injection of Pharmacologic Vitreolysis. Stratos Gotzaridis MD Athens
Early diagnosis and treatment of VMT with single Intravitreal Injection of Pharmacologic Vitreolysis Stratos Gotzaridis MD Athens The Vitreous Body Gel composed of 98-99% water 1% macromolecules Glycoproteins
More informationVMA at the macula resulting in VMT
Ocriplasmina for pharmacologic treatment in VMT Teresio Avitabile 1 Introduction PVD is a normal, physiologic process that occurs with aging; however, in some cases, PVD is incomplete Incomplete PVD localized
More informationFinancial Disclosures
Financial Disclosures Consultant Genentech, Regeneron, Allergan, Thrombogenics, Optos, and ArcticDx Grant Support Regeneron, Allergan Mathew W. MacCumber, MD, PhD Professor & Assoc. Chair for Research
More informationOPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT
OPTIC DISC PIT Pathogenesis and Management Abdel-Latif Siam Ain Shams University Cairo Egypt OPTIC DISC PIT Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated
More informationOutline. Outline. Vitreous Development & Anatomy OPT - 243
2010 OPT - 243 Vitreous Disorders & Vitreoretinal Disorders of the Posterior Pole I Leo Semes, OD, FAAO 100% 0% 0% 0% 0% Which of these gives the best resolution for studying vitreoretinal disorders of
More informationTreatment Options for VMT and Macular Holes Observation, Surgery, and Pharmacotherapy
Treatment Options for VMT and Macular Holes Observation, Surgery, and Pharmacotherapy Andrew Moshfeghi, MD, MBA Bascom Palmer Eye Institute Palm Beach Gardens, FL Financial Disclosures Salary/Honoraria:
More informationevaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography
evaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography Dr. Mahmoud Alaa Abouhusssein, FRCO Lecturer of ophthalmology, Alexandria university Dr. Amir Ramadan Gomaa, MD
More informationVitreo-retinal interface pathologies and fibrinolytic treatment approaches
Vitreo-retinal interface pathologies and fibrinolytic treatment approaches Constantin J. Pournaras Memorial A. de Rothschild Clinical Research Group La Colline Ophthalmology Center Vitreoretinal Interface
More informationOCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationEnzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Enzymatic Vitreolysis with for Vitreomacular Traction and Macular Holes Peter Stalmans, M.D., Ph.D., Matthew S. Benz, M.D., Arnd Gandorfer,
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationSudden Vision Loss. Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists
Sudden Vision Loss Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists My Credentials -Residency in Ophthalmology at the LSU Eye Center in New Orleans, LA -Fellowship
More informationUltrasonic examination in severe diabetic eye disease
British Journal of Ophthalmology, 1979, 63, 533-538 Ultrasonic examination in severe diabetic eye disease DAVID McLEOD AND MARIE RESTORI From the Department of Ultrasound, Moorfields Eye Hospital, City
More informationTHE NATURAL HISTORY OF TRACTIONAL CYSTOID MACULAR EDEMA
THE NATURAL HISTORY OF TRACTIONAL CYSTOID MACULAR EDEMA SOFIA CHARALAMPIDOU, MRCOPHTH,* JOHN NOLAN, PHD, STEPHEN BEATTY, FRCOPHTH* Background: To describe clinical outcomes in a series of patients with
More informationScleral buckling. Surgical Treatment
Dr. Ayman M. Khattab MD, FRCS professor of Ophthalmology Cairo University Surgical Treatment Pneumatic retinopexy. Primary pars plana vitrectomy. 1 Indications for scleral buckling. SB is used to treat
More informationRETINAL DETACHMENT AT THE POSTERIOR POLE*
Brit. J. Ophthal. (1958) 42, 749. RETINAL DETACHMENT AT THE POSTERIOR POLE* BY CALBERT I. PHILLIPSt Institute of Ophthalmology, University oflondon THE common feature of the cases to be described in this
More informationOcriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Traction. Baruch D Kuppermann, MD, PhD
Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Traction Baruch D Kuppermann, MD, PhD Professor of Ophthalmology and Biomedical Engineering; Chief, Service; Vice-Chair, Clinical Research,
More informationOften asymptomatic but can cause a reduction in BCVA and distortion of vision.
Christopher Wolfe, OD, FAAO, Dipl. ABO Epiretinal Membrane (ERM) and Vitreomacular Traction (VMT) Epiretinal membrane (macular pucker, cellophane maculopathy, premacular fibrosis) consists of a layer of
More informationVitreous Biochemistry and Pharmacologic Vitreolysis
CHAPTER 4 Vitreous Biochemistry and Pharmacologic Vitreolysis J. Sebag and Kevin R. Tozer Throughout history, medical therapeutics have advanced as a result of increased understanding of disease pathogenesis.
More informationCLINICAL COURSE OF VITREOMACULAR ADHESION MANAGED BY INITIAL OBSERVATION
CLINICAL COURSE OF VITREOMACULAR ADHESION MANAGED BY INITIAL OBSERVATION VISHAK J. JOHN, MD,* HARRY W. FLYNN, JR., MD,* WILLIAM E. SMIDDY, MD,* ADAM CARVER, MD, ROBERT LEONARD, MD, HOMAYOUN TABANDEH, MD,
More informationIntraoperative Visualization of Peripheral Retina with Wide-Angle Viewing Systems
Intraoperative Visualization of Peripheral Retina with Wide-Angle Viewing Systems Homayoun Tabandeh, M.D., MS, Francesco Boscia, M.D. 1. Retina -Vitreous Associates Medical Group, Los Angeles, California,
More informationHistology of the Eye
Histology of the Eye Objectives By the end of this lecture, the student should be able to describe: The general structure of the eye. The microscopic structure of:»cornea.»retina. EYE BULB Three coats
More informationOptical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.
Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to
More informationManaging the Vitreomacular Interface
Managing the Vitreomacular Interface A Guide to VMA, VMT, Holes and ERM Anna K. Bedwell, OD, FAAO Indiana University School of Optometry Please silence all mobile devices and remove items from chairs so
More informationA retrospective nonrandomized study was conducted at 3
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,
More informationAn A to Z guide on Epiretinal Membranes (ERMs) Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Department
An A to Z guide on Epiretinal Membranes (ERMs) Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Department Types of ERM Natural history OCT prognostic factors ERM with co-existing pathology
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationPROSPECTIVE THREE-DIMENSIONAL ANALYSIS OF STRUCTURE AND FUNCTION IN VITREOMACULAR ADHESION CURED BY PHARMACOLOGIC VITREOLYSIS
PROSPECTIVE THREE-DIMENSIONAL ANALYSIS OF STRUCTURE AND FUNCTION IN VITREOMACULAR ADHESION CURED BY PHARMACOLOGIC VITREOLYSIS Kevin R. Tozer, BS,* Wolfgang Fink, PhD, ** Alfredo A. Sadun, MD, PhD, FARVO,
More informationDiabetes & Your Eyes
Diabetes & Your Eyes Diabetes is a disease that occurs when the pancreas does not secrete enough insulin or the body is unable to process it properly. Insulin is the hormone that regulates the level of
More informationPRODUCT MONOGRAPH. Pr JETREA. ocriplasmin solution for intravitreal injection. 2.5 mg/ml. Professed Standard. Ophthalmological
PRODUCT MONOGRAPH Pr JETREA ocriplasmin solution for intravitreal injection 2.5 mg/ml Professed Standard Ophthalmological Sponsor: ThromboGenics N.V. Gaston Geenslaan 1 B-3001 Leuven Belgium Submission
More informationYasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD
Microperimetric Evaluation of Brilliant Blue G- assisted Internal Limiting Membrane Peeling By Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD The internal
More informationIntravitreal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment
(2006) 20, 423 427 & 2006 Nature Publishing Group All rights reserved 0950-222X/06 $30.00 www.nature.com/eye Intravitreal triamcinolone staining observation of residual undetached cortical vitreous after
More informationOishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.
Kimura T, Takagi H, Miyamoto K, Kita M, Watanabe D, Yoshimura N. Macular hole with epiretinal membrane after triamcinolone-assisted vitrectomy for proliferative diabetic retinopathy. Retinal Cases Brief
More informationCONTRAINDICATIONS None. (4)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JETREA safely and effectively. See full prescribing information for JETREA JETREA (ocriplasmin) injection,
More informationVitreomacular Traction: Management
Miscellaneous Refractive Surgery Vitreomacular Traction: Management Raji K. MS, DNB Raji K. MS, DNB, A.K. Upadhyay MS, S. Waikar MS, DNB, P. Tiwari MBBS Department of Ophthalmology, Command Hospital (WC)
More informationUveal Melanoma. Protocol applies to malignant melanoma of the uvea.
Uveal Melanoma Protocol applies to malignant melanoma of the uvea. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist) Biopsy (No Accompanying
More informationVITREOUS FLOATERS AND PHOTOPSIA AS PREDICTORS OF VITREORETINAL PATHOLOGY
Basrah Journal Of Surgery VITREOUS FLOATERS AND PHOTOPSIA AS PREDICTORS OF VITREORETINAL PATHOLOGY Salah Zuhair Al-Asadi MB,ChB, FRCS, FIBMS, Lecturer of Ophthalmology, College of Medicine, University
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More informationThe Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS
The Foundation American Society of Retina Specialists Committed to improving the quality of life of all people with retinal disease. Vitreomacular Traction Syndrome The vitreous humor is a transparent,
More informationCoagulative necrosis in a malignant melanoma of the choroid at the macula with extensive subretinal hemorrhage
Coagulative necrosis in a malignant melanoma of the choroid at the macula with extensive subretinal hemorrhage Robert D. Yee, Robert Y. Foos, and Bradley R. Straatsma The authors present a case report
More informationMACULAR EDEMA (ME) IS
LINIAL SIENES Intravitreal Plasmin Without Vitrectomy for Macular Edema Secondary to ranch Retinal Vein Occlusion Patricia Udaondo, MD; Manuel Díaz-Llopis, MD, PhD; Salvador García-Delpech, MD, PhD; David
More informationEfferent innervation of the retina
Efferent innervation of the retina II. Morphologic study of the monkey retina' Francisco M. Honrubia and James H. Elliott Silver impregnation of the monkey's retina has been employed to study the presence
More informationR&M Solutions
Mohamed Hosny El-Bradey, MD., Assistant Professor of Ophthalmology, Tanta University. Wael El Haig, MD., Professor of Ophthalmology. Zagazeeg University. 1 Myopic CNV is considered the most common vision
More informationChorioretinal vascular occlusions with latex microspheres (a long-term study). Part II. Howard Golclor and Andrew J. Gay
Chorioretinal vascular occlusions with latex microspheres (a long-term study). Part II Howard Golclor and Andrew J. Gay The results of a long-term study (3 to 9 months) of chorioretinal vascular occlusions
More informationDehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution
Hirota et al. BMC Ophthalmology 2014, 14:39 RESEARCH ARTICLE Open Access Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution Kazunari
More informationTechnique. 92i. M. M. J. McNicholas, 2 D. P. Brophy,1 W. J. Power,3 4 and J. F. Griffin1 3
92i Ocular Sonography M. M. J. McNicholas, 2 D. P. Brophy,1 W. J. Power,3 4 and J. F. Griffin1 3 High-frequency ocular sonography is the ideal method for imaging the eye and intraocular structures. In
More informationVitreomacular interface disorders. Ghanbari MD 1393:10:25
Vitreomacular interface disorders Ghanbari MD 1393:10:25 Human vitreous after dissection of the sclera, choroid, and retina. Lamellar structure of the posterior vitreous cortex (PVC) in the monkey. V =
More informationPRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique
Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with
More informationLong-term Outcomes of Vitreous Floaters Management with 23-Gauge Transconjunctival Sutureless Vitrectomy
Long-term Outcomes of Vitreous Floaters Management with 23-Gauge Transconjunctival Sutureless Vitrectomy Malhar 1Consultant 1 Soni, Minas G 2 Georgopoulos, Adriana 2 Kovakova Vitreo-Retinal Surgeon, London,
More informationEPIRETINAL MEMBRANE & VITREOMACULAR TRACTION
EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION Management of ERM and VMT K.V.Chalam,MD,PhD,MBA,FACS Professor and Director of Retina Loma Linda Eye Institute Los Angeles, USA REVIEW ANATOMY The vitreous
More informationVanderbilt Eye Institute Clinical Trials
April, 2010 Vanderbilt Eye Institute Clinical Trials Ophthalmology Actively Recruiting Studies For information on our clinical trials and other studies, please contact: Sandy Owings, COA, CCRP Clinic Director
More informationoptic disc neovascularisation
British Journal of Ophthalmology, 1979, 63, 412-417 A comparative study of argon laser and krypton laser in the treatment of diabetic optic disc neovascularisation W. E. SCHULENBURG, A. M. HAMILTON, AND
More informationPosterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study
Posterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study Sung Jun Lee Department of Medicine The Graduate School, Yonsei University Posterior Vitreomacular
More informationVitreomacular Traction
Supplement to March 2014 Rethink Vitreomacular Traction With articles by Pravin U. Dugel, MD Anselm Kampik, MD J. Sebag, MD, FACS, FRCOphth, FARVO Ramin Tadayoni, MD, PhD Sponsored by Alcon The articles
More informationEccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case Report
Ophthalmol Ther (2017) 6:391 395 DOI 10.1007/s40123-017-0113-7 CASE REPORT Eccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case
More informationAnina Abraham, Consultant, Swarup Eye Centre, Hyderabad, India. The author has no financial interests
Reduced Incidence of Sclerotomy Related Breaks during 23-Gauge Vitrectomy Anina Abraham, Consultant, Swarup Eye Centre, Hyderabad, India The author has no financial interests Introduction Sclerotomy related
More informationDiabetic eye disease. Diabetic retinopathy. Sam S. Dahr, M.D. Retina Center of Oklahoma.
Diabetic eye disease Sam S. Dahr, M.D. Retina Center of Oklahoma www.rcoklahoma.com Downloaded from: The Retina (on 28 May 2007 12:48 AM) 2007 Elsevier Diabetic retinopathy Downloaded from: The Retina
More informationRelated Policies None
Medical Policy BCBSA Ref. Policy: 9.03.30 Last Review: 03/29/2018 Effective Date: 03/29/2018 Section: Other Related Policies None DISCLAIMER Our medical policies are designed for informational purposes
More informationExperimental retinal detachment with a sulfated polysaccharide
Experimental retinal detachment with a sulfated polysaccharide Wallace M. Landholm and Robert C. Watzke C, Research in the pathophysiology of retinal detachments would be aided if an experimental model
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationPREDICTIVE FACTORS OF VISUAL OUTCOME FOR VITREOMACULAR TRACTION SYNDROME AFTER VITRECTOMY
PREDICTIVE FACTORS OF VISUAL OUTCOME FOR VITREOMACULAR TRACTION SYNDROME AFTER VITRECTOMY Downloaded from https://journals.lww.com/retinajournal by mv7bzw+nz2blpko//cqyhwu2mokppdiwuep6ir1molueskh0dp9rbmb7dum5a2/cp6zifirtq3zbawzt+95f/m61fycawpqbpe8y2wuyzwnns2gw3+gmrxei6x11wu+s
More informationEyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD
EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina Retinal Arcades Macula Optic
More informationCLINICAL SCIENCES. Visual Field Defects After Intravitreous Administration of Indocyanine Green in Macular Hole Surgery
CLINICAL SCIENCES Visual Field Defects After Intravitreous Administration of Indocyanine Green in Macular Hole Surgery Shigeru Kanda, MD; Akinori Uemura, MD; Takehiro Yamashita, MD; Hazuki Kita, MD; Keita
More informationYara Saddam. Amr Alkhatib. Ihsan
1 Yara Saddam Amr Alkhatib Ihsan NOTE: Yellow highlighting=correction/addition to the previous version of the sheet. Histology (micro anatomy) :- the study of tissues and how they are arranged into organs.
More informationVitrectomy Prevents Retinal Hypoxia in Branch Retinal Vein Occlusion
Investigative Ophthalmology & Visual Science, Vol. 31, No. 2, February 1990 Copyright Association for Research in Vision and Ophthalmology Vitrectomy Prevents Retinal Hypoxia in Branch Retinal Vein Occlusion
More informationOphthalmology. Juliette Stenz, MD
Ophthalmology Juliette Stenz, MD Required Slide Disclosures NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT Required Slide At the end of this session, students will be able to: 1.
More informationMoncef Khairallah, MD
Moncef Khairallah, MD Department of Ophthalmology, Fattouma Bourguiba University Hospital Faculty of Medicine, University of Monastir Monastir, Tunisia INTRODUCTION IU: anatomic form of uveitis involving
More informationPlatelet-induced vitreous membrane formation*
Platelet-induced vitreous membrane formation* Ian J. Constable, Masami Oguri, Carolyn M. Chesney, David A. Swann, and Robert W. Colman The role of extravascular coagulation in vitreous membrane formation
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationIntercellular Matrix in Colonies of Candida
JouRNAL OF BAcTEROLOGY, Sept. 1975, p. 1139-1143 Vol. 123, No. 3 Copyright 0 1975 American Society for Microbiology Printed in U.S.A. ntercellular Matrix in Colonies of Candida K. R. JOSH, J. B. GAVN,*
More informationMichael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015
Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 So What Parts of the Eye Retina are Affected by VHL Neural tissue
More informationOptometric Postoperative Cataract Surgery Management
Financial Disclosures Optometric Postoperative Cataract Surgery Management David Dinh, OD Oak Cliff Eye Clinic Dallas Eye Consultants March 10, 2015 Comanagement Joint cooperation between two or more specialists
More informationI need to acknowledge Dr. Inder Paul Singh for providing slides for this presentation
I need to acknowledge Dr. Inder Paul Singh for providing slides for this presentation DISCLOSURES I AM A: CONSULTANT TO ELLEX SPEAKER FOR ELLEX RESEARCH FOR ELLEX It s a really good laser for capsulotomies
More informationDistribution of type IV collagen, laminin, nidogen and fibronectin in the haemodynamically stressed vascular wall
Histol Histopath (1 990) 5: 161-1 67 Histology and Histopathology Distribution of type IV collagen, laminin, nidogen and fibronectin in the haemodynamically stressed vascular wall Reinhold Kittelberger,
More informationPharmacology and Vitreoretinal Surgery
Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology Vol. 44 Series Editor W. Behrens-Baumann Magdeburg Section Title Pharmacology and Vitreoretinal Surgery Volume Editor Arnd Gandorfer
More informationStudy of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema
Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali
More informationMacular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage
Published online: September 15, 2015 2015 The Author(s) Published by S. Karger AG, Basel 1663 2699/15/0063 0328$39.50/0 This article is licensed under the Creative Commons Attribution-NonCommercial 4.0
More informationDetermination of the Distribution of Cilia on the Surface of the Mantle of Cypraea caputserpentis utilizing Scanning Electron Microscopy
Determination of the Distribution of Cilia on the Surface of the Mantle of Cypraea caputserpentis utilizing Scanning Electron Microscopy DURATION September 10, 1990- May 7, 1991 Tracie A. Yokoi Advisor
More informationScanning Electron Microscopy of Thiobacilli
Arch. Microbiol. 99, 323-329 (1974) 0 by Springer-Verlag 1974 Scanning Electron Microscopy of Thiobacilli Grown on Colloïdal Sulfur J. Baldensperger", L. J. Guarraia**, and W. J. Humphreys*** Department
More informationVitrectomy Combined with Phacoemulsification and Intraocular Lens Implantation for Diabetic Macular Edema
Vitrectomy Combined with Phacoemulsification and Intraocular Lens Implantation for Diabetic Macular Edema Kentaro Amino* and Hidenobu Tanihara *Amino Eye Clinic, Shimonoseki, Yamaguchi Prefecture, Japan;
More information1.1 Terminology of Mechanical Injuries: the Birmingham Eye Trauma Terminology (BETT)
1.1 Terminology of Mechanical Injuries: the Birmingham Eye Trauma Terminology (BETT) Ferenc Kuhn, Robert Morris, Viktória Mester, C. Douglas Witherspoon 1.1.1 If the Terminology Is Not Standardized Akin
More informationA Patient s Guide to Diabetic Retinopathy
Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes
More informationMeasure #192: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
Measure #192: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures 2012 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationInitially, the patients did not receive extra vitamin E except for a very
EFFECT OF VITAMIN E ON MEMBRANES OF THE INTESTINAL CELL BY I. MOLENAAR, F. A. HOMMES, W. G. BRAAMS, AND H. A. POLMAN CENTER FOR MEDICAL ELECTRON MICROSCOPY AND DEPARTMENT OF PEDIATRICS, UNIVERSITY OF GRONINGEN,
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationLeo Semes, OD, FAAO UAB Optometry
Leo Semes, OD, FAAO UAB Optometry Safe; inert Has long track record - over 45 years Mixes with plasma and highlights blood vessel compromise Using specific exciting (490 nm)and absorption (510 nm) filters
More informationZEISS AngioPlex OCT Angiography. Clinical Case Reports
Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy
More informationOptical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP
Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features
More informationVenturi versus peristaltic pumps 33 vitrectomy dynamics 34 Fluorescein, vitreous staining 120
Subject Index Accurus 35, 83 Aflibercept, diabetic macular edema management 167, 168 Air-forced infusion, Stellaris PC 12, 13 Alcon Constellation, see Constellation system Autoclave sterilization lens
More informationLongitudinal Validation Study: Streptozotocin-Induced Diabetes as a Model of Diabetic Retinopathy in Brown Norway Rats
Longitudinal Validation Study: Streptozotocin-Induced Diabetes as a Model of Diabetic Retinopathy in Brown Norway Rats Robin Dean, Robert Sukhu, Leslie Nemeth, Qin Zhang, Isaac Hakim, Ali Ebramhimnejad,
More informationOCT Angiography in Primary Eye Care
OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central
More informationXUE HUI Department of Histology& Embryology, Basic Medicine College of Jilin University
SENSE ORGAN XUE HUI Department of Histology& Embryology, Basic Medicine College of Jilin University EYE fibrous globe lens photosensitive cells a system of cells and nerves concentric layers the sclera
More informationTHE EYE: RETINA AND GLOBE
Neuroanatomy Suzanne Stensaas February 24, 2011, 10:00-12:00 p.m. Reading: Waxman Ch. 15. Your histology and gross anatomy books should be useful. Reading: Histology of the Eye from any histology book
More informationIntroduction. Donor tissue preparation for Descemet Membrane Endothelial ASCRS Aim of dissection. DMEK graft preparation
Introduction Donor tissue preparation for Descemet Membrane Endothelial keratoplasty (DMEK) ASCRS - 2015 Endothelial Keratoplasty DSAEK / DSEK DMEK Donor lamellae stroma + DM + endothelium DM + endothelium
More informationJETREA CARE Provides JETREA At No Cost
JETREA CARE Provides JETREA At No Cost to All Qualifying Patients Who Do Not Have Insurance JETREA CARE Patient Assistance Program Your Health Insurance Coverage No Insurance (Uninsured) Your Potential
More informationCystoid macular edema associated with limbal melanoma*
Graefe's Arch Clin Exp Ophthalmol (1983) 221:101-105 Graefe's Archive for CliniCal and Experimental Ophthalmology Springer-Verlag 1983 Cystoid macular edema associated with limbal melanoma* J. Reimer Wolter
More informationCataract surgery is the leading cause of malpractice claims (OMIC) Complicated CE/IOL: Choices the anterior segment surgeon can make
Posterior Segment Complications and Management of Retained Lens Material Jay M. Stewart, MD Cataract surgery is the leading cause of malpractice claims (OMIC) Complicated CE/IOL: Choices the anterior segment
More informationPharmacology and Vitreoretinal Surgery
Pharmacology and Vitreoretinal Surgery Developments in Ophthalmology Vol. 44 Series Editor W. Behrens-Baumann Magdeburg Section Title Pharmacology and Vitreoretinal Surgery Volume Editor Arnd Gandorfer
More informationEssentials in Ophthalmology. Series Editor Arun D. Singh. For further volumes:
Essentials in Ophthalmology Series Editor Arun D. Singh For further volumes: http://www.springer.com/series/5332 Aniz Girach Marc D. de Smet Editors Arun D. Singh Series Editor Diseases of the Vitreo-Macular
More information